Lyka Labs Ltd

NSE: LYKALABS · BSE: 500259 · Pharmaceuticals & Biotechnology · 30 announcements

Share price: ₹81.35
Market cap: ₹290.3 Cr
Revenue (annual): ₹128.4 Cr
Net profit (annual): ₹-10.03 Cr
P/E (TTM): -68.2×Sector 43.8×
Promoter holding: 58.45%+0.00% QoQ
FII holding: 0.15%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Results Update 1 Other Announcement 1 Management Change 1 Legal & Regulatory 1 Financial Results 1 Board Meeting Date 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

30 Oct 2026 18:48 IST BSE

Management Change

Lyka Labs Management Change

Lyka Labs re-appointed Neeraj Golas as Non-Executive Independent Director for 36 months, effective 16 January 2027. The board approved it at its 30 October 2026 meeting.

Execution: 36 months from 16 January 2027

Open announcement → Read the filing ↗